A Proactive Telephone-Delivered Risk Communication Intervention for Smokers Participating in Lung Cancer Screening: A Pilot Feasibility Trial

被引:8
|
作者
Zeliadt, Steven B. [1 ,2 ]
Greene, Preston A. [1 ]
Krebs, Paul [3 ,4 ]
Klein, Deborah E. [5 ]
Feemster, Laura C. [1 ,6 ]
Au, David H. [1 ,6 ]
Slatore, Christopher G. [7 ,8 ]
Heffner, Jaimee L. [9 ]
机构
[1] VA Puget Sound Hlth Care Syst, Ctr Innovat Vet Ctr & Value Driven Care, Seattle, WA USA
[2] Univ Washington, Sch Publ Hlth, Dept Hlth Serv, Seattle, WA 98195 USA
[3] New York Harbor VA Hlth Care Syst, New York, NY USA
[4] NYU, Sch Med, New York, NY USA
[5] Swedish Med Grp, Seattle, WA USA
[6] Univ Washington, Div Pulm & Crit Care Med, Seattle, WA 98195 USA
[7] Portland VA Med Ctr, Ctr Improve Vet Involvement Care Hlth Serv Res &, Portland, OR USA
[8] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA
[9] Fred Hutchinson Canc Res Ctr, Tobacco & Hlth Behav Sci Res Grp, 1124 Columbia St, Seattle, WA 98104 USA
来源
JOURNAL OF SMOKING CESSATION | 2018年 / 13卷 / 03期
关键词
D O I
10.1017/jsc.2017.16
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: Many barriers exist to integrating smoking cessation into delivery of lung cancer screening including limited provider time and patient misconceptions.Aims: To demonstrate that proactive outreach from a telephone counsellor outside of the patient's usual care team is feasible and acceptable to patients.Methods: Smokers undergoing lung cancer screening were approached for a telephone counselling study. Patients agreeing to participate in the intervention (n = 27) received two telephone counselling sessions. A 30-day follow-up evaluation was conducted, which also included screening participants receiving usual care (n = 56).Results/Findings: Most (89%) intervention participants reported being satisfied with the proactive calls, and 81% reported the sessions were helpful. Use of behavioural cessation support programs in the intervention group was four times higher (44%) compared to the usual care group (11%); Relative Risk (RR) = 4.1; 95% CI: 1.7 to 9.9), and seven-day abstinence in the intervention group was double (19%) compared to the usual care group (7%); RR = 2.6; 95% CI: 0.8 to 8.9).Conclusions: This practical telephone-based approach, which included risk messages clarifying continued risks of smoking in the context of screening results, suggests such messaging can boost utilisation of evidence-based tobacco treatment, self-efficacy, and potentially increase the likelihood of successful quitting.
引用
收藏
页码:137 / 144
页数:8
相关论文
共 50 条
  • [41] Mobile health - delivered narrative intervention to increase cervical cancer screening among Malawian women living with HIV: A pilot randomized controlled trial
    Lee, Haeok
    Mtengezo, Jasintha T.
    Makin, Mary Sue
    Shi, Ling
    Malata, Address
    Fitzpatrick, Joyce
    Ngoma, Jonathan
    Zhang, Lingling
    Larkey, Linda
    Stuart-Shor, Eileen
    Mlombe, Yohannie
    Kim, Deogwoon
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2024, 11 (05)
  • [42] Study protocol for a pilot randomised controlled trial of a virtually delivered behavioural intervention (ACTION) for adults with cancer at risk for opioid use disorder
    Yusufov, Miryam
    Pirl, William F.
    Greer, Joseph A.
    Mazzola, Emanuele
    Dalrymple, Kristy L.
    Tulsky, James A.
    Braun, Ilana M.
    Mchugh, R. Kathryn
    BMJ OPEN, 2024, 14 (12):
  • [43] Feasibility and Acceptability of a Remotely Delivered, Web-Based Behavioral Intervention for Men With Prostate Cancer: Four-Arm Randomized Controlled Pilot Trial
    Chan, June M.
    Van Blarigan, Erin L.
    Langlais, Crystal S.
    Zhao, Shoujun
    Ramsdill, Justin W.
    Daniel, Kimi
    Macaire, Greta
    Wang, Elizabeth
    Paich, Kellie
    Kessler, Elizabeth R.
    Beer, Tomasz M.
    Lyons, Karen S.
    Broering, Jeanette M.
    Carroll, Peter R.
    Kenfield, Stacey A.
    Winters-Stone, Kerri M.
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2020, 22 (12)
  • [44] Preliminary results from a patient group, excluded from the National Lung Cancer Screening Trial, who are at high risk for lung cancer- heavy smokers with HIV
    Hulbert, Alicia
    Hooker, Craig
    Brown, Travis
    Horton, Karen
    Wrangle, John
    Fishman, Elliott
    Pelosky, Kristen
    Lee, Beverley
    Shin, James
    Rutlege, Marian
    Sam, Celis
    Pridham, Genevieve
    Lee, Sue
    Luong, Eli
    Carter, Yvonne
    Brown, Robert
    Herman, James
    Brock, Malcolm
    CANCER RESEARCH, 2011, 71
  • [45] Report on a Phytochemical-rich Dietary Intervention Trial to Prevent Lung Cancer: Implementation in a High-Risk Lung Screening Clinic
    Bittoni, M.
    Bibi, A.
    Williams, N.
    Mendelson, M.
    Grainger, E.
    Vodovitz, Y.
    Riedl, K.
    Clinton, S.
    Carbone, D.
    Spakowicz, D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S470 - S471
  • [46] Japan Diabetes Outcome Intervention Trial-1 (J-DOIT1): A Cluster Randomized Controlled Trial of Type 2 Diabetes (T2DM) Prevention by Telephone-Delivered Lifestyle Support for High-Risk Subjects
    Sakane, Naoki
    Okazaki, Kentaro
    Kotani, Kazuhiko
    Takahashi, Kaoru
    Sano, Yoshiko
    Tsuzaki, Kokoro
    Sato, Juichi
    Suzuki, Sadao
    Morita, Satoshi
    Oshima, Yoshitake
    Izumi, Kazuo
    Kato, Masayuki
    Ishizuka, Naoki
    Noda, Mitsuhiko
    Kuzuya, Hideshi
    DIABETES, 2013, 62 : A320 - A320
  • [47] Validation of multivariable lung cancer risk prediction models for the personalized assignment of optimal screening frequency: a retrospective analysis of data from the German Lung Cancer Screening Intervention Trial (LUSI)
    Maldonado, Sandra Gonzalez
    Hynes, Lucas Cory
    Motsch, Erna
    Heussel, Claus-Peter
    Kauczor, Hans-Ulrich
    Robbins, Hilary A.
    Delorme, Stefan
    Kaaks, Rudolf
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (03) : 1305 - +
  • [48] Feasibility of a behavioral intervention using mobile health applications to reduce cardiovascular risk factors in cancer survivors: a pilot randomized controlled trial
    Chow, Eric J.
    Doody, David R.
    Di, Chongzhi
    Armenian, Saro H.
    Baker, K. Scott
    Bricker, Jonathan B.
    Gopal, Ajay K.
    Hagen, Anna M.
    Ketterl, Tyler G.
    Lee, Stephanie J.
    Reding, Kerryn W.
    Schenk, Jeannette M.
    Syrjala, Karen L.
    Taylor, Sarah A.
    Wang, Guangxing
    Neuhouser, Marian L.
    Mendoza, Jason A.
    JOURNAL OF CANCER SURVIVORSHIP, 2021, 15 (04) : 554 - 563
  • [49] Feasibility of a behavioral intervention using mobile health applications to reduce cardiovascular risk factors in cancer survivors: a pilot randomized controlled trial
    Eric J. Chow
    David R. Doody
    Chongzhi Di
    Saro H. Armenian
    K. Scott Baker
    Jonathan B. Bricker
    Ajay K. Gopal
    Anna M. Hagen
    Tyler G. Ketterl
    Stephanie J. Lee
    Kerryn W. Reding
    Jeannette M. Schenk
    Karen L. Syrjala
    Sarah A. Taylor
    Guangxing Wang
    Marian L. Neuhouser
    Jason A. Mendoza
    Journal of Cancer Survivorship, 2021, 15 : 554 - 563
  • [50] Serum-based biomarkers associated with lung cancer risk and cause-specific mortality in the German randomized Lung Cancer Screening Intervention (LUSI) trial
    Cortes-Ibanez, Francisco O.
    Johnson, Theron
    Mascalchi, Mario
    Katzke, Verena
    Delorme, Stefan
    Kaaks, Rudolf
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (12) : 2460 - 2475